Stock DNA
Pharmaceuticals & Biotechnology
CNY 8,668 Million (Mid Cap)
46.00
NA
0.96%
-0.28
7.84%
3.57
Revenue and Profits:
Net Sales:
171 Million
(Quarterly Results - Jun 2025)
Net Profit:
50 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-12.47%
0%
-12.47%
6 Months
3.64%
0%
3.64%
1 Year
11.89%
0%
11.89%
2 Years
-6.76%
0%
-6.76%
3 Years
-63.06%
0%
-63.06%
4 Years
-75.36%
0%
-75.36%
5 Years
-72.23%
0%
-72.23%
Zhejiang Ausun Pharmaceutical Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
14.90%
EBIT Growth (5y)
20.33%
EBIT to Interest (avg)
62.16
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.28
Sales to Capital Employed (avg)
0.31
Tax Ratio
13.53%
Dividend Payout Ratio
40.14%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
16.62%
ROE (avg)
11.06%
Valuation key factors
Factor
Value
P/E Ratio
46
Industry P/E
Price to Book Value
3.57
EV to EBIT
50.28
EV to EBITDA
35.32
EV to Capital Employed
4.56
EV to Sales
10.35
PEG Ratio
NA
Dividend Yield
0.96%
ROCE (Latest)
9.06%
ROE (Latest)
7.84%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
171.40
305.10
-43.82%
Operating Profit (PBDIT) excl Other Income
58.00
141.50
-59.01%
Interest
1.90
1.70
11.76%
Exceptional Items
-0.30
0.80
-137.50%
Consolidate Net Profit
50.10
119.20
-57.97%
Operating Profit Margin (Excl OI)
236.70%
406.60%
-16.99%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is -43.82% vs 205.71% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is -57.97% vs 636.94% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
783.80
810.20
-3.26%
Operating Profit (PBDIT) excl Other Income
243.20
281.60
-13.64%
Interest
8.00
8.30
-3.61%
Exceptional Items
5.50
-4.50
222.22%
Consolidate Net Profit
206.80
253.90
-18.55%
Operating Profit Margin (Excl OI)
229.10%
297.40%
-6.83%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -3.26% vs 6.47% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -18.55% vs 7.86% in Dec 2023
About Zhejiang Ausun Pharmaceutical Co., Ltd. 
Zhejiang Ausun Pharmaceutical Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






